There is a need for education and support around the long-term effects of acute myeloid #leukemia (#AML) treatment. Today is #AMLAwarenessDay, when people from all over the world unite to help raise awareness of this rare aggressive cancer of the blood and bone marrow.

Rigel Pharmaceuticals $RIGL will report its first quarter 2025 financial results after market close on Tuesday, May 6, 2025. Rigel senior management will follow the announcement with a live conference call and webcast.

Today, $RIGL reported Q1 2025 financial results and provided a business update. Read our press release: rigel.com/news-media/pre… Listen to our webcast at 1:30pm PT/4:30pm ET: rigel.com/investors/news…

Clinical research is critical to advancing the state of care for everyone. On #ClinicalTrailsDay, we would like to thank the patients, physicians, investigators and their families for their partnership and participation in our clinical trials. Learn More: clinicaltrialsday.org

$RIGL announced several posters highlighting the strength of the Company's hematology and oncology portfolio at the upcoming ASCO Annual Meeting. Click here for the press release: rigel.com/news-media/pre… To learn more about Rigel, visit Booth #14131 during #ASCO25

This month $RIGL celebrates pride, love, and equality. Diversity is strength, and together we are stronger.

$RIGL CEO, Raul Rodriguez, will present a company overview at the Jefferies Global Healthcare Conference on Wednesday, June 4th at 12:50 pm ET in New York. url.us.m.mimecastprotect.com/s/GLWcC68jZ3fP…

$RIGL will have three posters highlighting data on olutasidenib (REZLIDHIA) on Friday at #EHA2025. Click here for the press release and poster details: rigel.com/investors/news…

$RIGL partner Kissei has announced launch of TAVALISSE® (fostamatinib disodium hexahydrate) in South Korea. Click here for press release: kissei.co.jp/e_contents/new…

$RIGL to report Q2 2025 financial results and provide an update on the business on August 5th. Click here for details: rigel.com/investors/news…

Today, $RIGL reported Q2 2025 financial results and provided a business update. Link to press release: rigel.com/investors/news… Listen to the webcast today at 4:30 p.m. ET: event.choruscall.com/mediaframe/web…

We’ve been gatekeeping long enough! 🔑 For more than 75 years, we’ve been committed to creating a world without blood cancer. While our mission hasn’t changed, today, our name does. 📣 📰 Headline this moment—go!👇

The child who just wants to get back to school. The parent who hopes for better days. The survivor still figuring out what comes next. As Blood Cancer United, we’re still doing the most for every person facing blood cancer. ❤️

September is #ITPawareness Month, and Rigel is supporting the ITP community and PDSA ITP SUPPORT. Join us in helping to drive ITP awareness all month long. #LightUp4ITP

$RIGL CEO, Raul Rodriguez, to provide a company update at the 2025 Cantor Global Healthcare Conference on September 3rd at 8:35 am ET. Click here for details: rigel.com/news-media/pre…

$RIGL CFO, Dean Schorno, to provide a company update at the H.C. Wainwright & Co. Global Investment Conference on September 9th at 1:30pm ET. Click here for details: rigel.com/news-media/pre… #HCWConference

Living with chronic #ITP? Inhibiting spleen tyrosine kinase (SYK) is a different approach to treatment that might be right for you. Learn how it works protectyourplatelets.com #ITPawareness #LightUp4ITP

Sport Purple for Platelets Day is coming Friday, September 26! Show your support for patients with chronic ITP and raise #ITPawareness. #Purple4Platelets #PaintThePlanetPurple